{"product_id":"riflux-0-15-x-30-tabl-stomach-ulcer-ulcer-treatment","title":"RIFLUX 0.15 x 30 tabl. stomach ulcer, ulcer treatment","description":"\u003cdiv class=\"projector_description description\" itemprop=\"description\"\u003e \u003cul\u003e \u003cli\u003e\u003cspan\u003eRIFLUX. S\u003cspan class=\"spGb-e spGb-h\"\u003etomach ulcer, ulcer treatment.\u003c\/span\u003e\u003ca class=\"spGb-f\" aria-label=\"Actions for keyword 'stomach ulcer'\"\u003e \u003c\/a\u003eThe formulation at a dose of 150 mg is recommended in the treatment of gastric and duodenal ulcer, also associated with Helicobacter pylori;\u003cspan\u003e \u003c\/span\u003eprevention of recurrence of ulcers of the stomach and duodenum.\u003c\/span\u003e\u003c\/li\u003e \u003c\/ul\u003e \u003c\/div\u003e \u003cdiv class=\"component_projector_longdescription\"\u003e \u003cdiv class=\"n56174_main\"\u003e \u003cp\u003e\u003cstrong\u003e\u003cspan\u003eComposition:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eEach tablet contains:\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eactive substance 150 mg of ranitidine hydrochloride salt (equivalent to 168 mg of ranitidine hydrochloride)\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eexcipients: citrate, monosodium, sodium benzoate, aspartame, sodium bicarbonate, povidone K-25, macrogol 6000, flavor, grapefruit, orange flavor , natural colorant.\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003e1 tablet contains 328 mg of sodium.\u003c\/span\u003e\u003c\/p\u003e \u003cp\u003e\u003cstrong\u003e\u003cspan\u003eAction:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eThe drug inhibits basal and stimulated gastric acid secretion by parietal cells in the gastric mucosa.\u003cspan\u003e \u003c\/span\u003eAbsorbed from the gastrointestinal tract.\u003cspan\u003e \u003c\/span\u003eOperation of a single tablet formulation begins within a few minutes and lasts for 12 hours.\u003cspan\u003e \u003c\/span\u003ePeak plasma concentrations occur after about 2 hours.\u003c\/span\u003e\u003c\/p\u003e \u003cp\u003e\u003cstrong\u003e\u003cspan\u003eIndications:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003e- treatment of ulcers of the stomach and duodenum;\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003e- prevention and treatment of gastric and duodenal ulcers, occurring during the use of\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003enon-steroidal anti-inflammatory drugs;\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003e-owrzodzenie occurring after stomach operations (anastomotic ulcer);\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003e- Zollinger - Ellison syndrome;\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003e- gastroesophageal reflux disease;\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003e- alleviation of symptoms of recurrent dyspepsia not associated with evidence of organic disease\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eof the gastrointestinal tract;\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003e- prevention of stress ulcers in critically ill patients;\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003e- prevention of Mendelson syndrome (aspiration of gastric acid before\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003egeneral anesthesia in patients in whom there is such a risk).\u003c\/span\u003e\u003c\/p\u003e \u003cp\u003e\u003cstrong\u003e\u003cspan\u003eDosage:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eAdults:\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003egastric ulcer and duodenal ulcer, gastric postoperative treatment - one tablet of 150 mg two times a day, morning and evening, or a single 300 mg at bedtime.\u003cspan\u003e \u003c\/span\u003eIn most patients, healing of the ulcer after 4 weeks.\u003cspan\u003e \u003c\/span\u003ePatients who have not healed ulcer at this stage of treatment, healing usually occurs during the ensuing 4 weeks.\u003cspan\u003e \u003c\/span\u003ePrevention of relapse of peptic ulcer - one tablet of 150 mg at bedtime\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003esores occurring during the use of nonsteroidal anti-inflammatory drug treatment - one tablet of 150 mg two times a day or 300 mg once at night, for a period of 8 to 12 weeks.\u003cspan\u003e \u003c\/span\u003ePrevention - one tablet of 150 mg two times a day.\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003egastro - disease, alleviation of symptoms - one tablet of 150 mg two times daily for up to two weeks.\u003cspan\u003e \u003c\/span\u003eIf necessary, treatment can be extended for a further two weeks.\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eReflux esophagitis - the recommended dosage is 150 mg two times a day, or a single 300 mg at bedtime for a period of 8 to 12 weeks.\u003cspan\u003e \u003c\/span\u003eIn patients with severe esophagitis dose of ranitidine may be increased to 4 times daily 150 mg.\u003cspan\u003e \u003c\/span\u003eTreatment should last for the 12 weeks.\u003cspan\u003e \u003c\/span\u003eIn the maintenance treatment of reflux oesophagitis, the recommended dose is 150 mg two times a day.\u003c\/span\u003e\u003c\/p\u003e \u003cp\u003e\u003cspan\u003erecurrent dyspepsia - one tablet of 150 mg, if necessary, two times daily for up to 6 weeks.\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eprevention of stress ulceration in seriously ill patients - one tablet of 150 mg at bedtime\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eZollinger - Ellison Syndrome - A starting dose of 150 mg three times daily and, if necessary, can be increased to 600 - 900 mg per day.\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003epreventing syndrome Mendelson - 150 mg in the evening before anesthesia and 150 mg 2 hours before anesthesia.\u003c\/span\u003e\u003c\/p\u003e \u003cp\u003e\u003cstrong\u003e\u003cspan\u003eChildren:\u003c\/span\u003e\u003cbr\u003e\u003c\/strong\u003e\u003cspan\u003etreatment of gastric ulcers - recommended oral dose is from 2 to 4 mg \/ kg two times a day.\u003cspan\u003e \u003c\/span\u003eDo not exceed the dose of 300 mg daily.\u003c\/span\u003e\u003c\/p\u003e \u003c\/div\u003e \u003c\/div\u003e\u003cspan class=\"pirate_product\" id=\"pirate_product_10816015623\"\u003e\u003c\/span\u003e","brand":"Polfarmex","offers":[{"title":"Default Title","offer_id":54931626885497,"sku":"RIFLUX 0.15 x 30 tabl. stomach ulcer, ulcer treatment","price":14.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0903\/0792\/0249\/files\/riflux-0-15-x-30-tabl-stomach-ulcer-ulcer-treatment-uk.jpg?v=1738867235","url":"https:\/\/ukdorf.co.uk\/products\/riflux-0-15-x-30-tabl-stomach-ulcer-ulcer-treatment","provider":"UKDorf (ELIVERA) Buy online, Reviews Est. 1988 London, UK.","version":"1.0","type":"link"}